Therapeutics for Eliminating Hepatitis B Virus cccDNA (R21/R33 Clinical Trial Not Allowed)
Department of Health and Human Services National Institutes of Health
Typ
Research/project funding
Posted on:
Bewerbungsschluss:
Expired
Reference Number
RFA-AI-22-068
The purpose of this Funding Opportunity Announcement is to invite applications aimed at discovery of new antivirals that result in the elimination or suppression of HBV ccc DNA from infected cells.
Categories: Health.
Categories: Health.
USA